Elevated circulating FGF21 levels have been associated with conditions characterized by hepatic insulin-resistance (metabolic syndrome [37], nonalcoholic fatty liver disease (NAFLD) [38], and T2DM [39]). The gene discussed is FGF21; the disease is Insulin resistance.